RedChip Companies

RedChip is the world leader in investor relations, financial media, and research for microcap and small-cap stocks. RedChip has helped hundreds of companies achieve their capital markets goals and has been ranked by Inc. Magazine as one of the fastest growing privately held investor relations firms in the U.S. #finance #capitalmarkets #investorrelations

📢 ASP Isotopes (Nasdaq: ASPI) Strengthens Leadership Team with Latest Board Changes ASP Isotopes has appointed veteran South African executive Sipho Maseko—former CEO of Telkom SA and MD of Vodacom SA—to its Board of Directors, strengthening its leadership as it expands advanced isotope and nuclear fuel initiatives. 💼 Key Leadership Moves: - Maseko brings decades of executive experience and deep ties to South Africa’s industrial and energy sectors. - Dr. Hendrik Strydom, PhD, transitions from ASP Isotopes' board to Quantum Leap Energy (QLE), focusing on advanced nuclear fuels like HALEU and Lithium-6. 🔄 Why This Matters for Investors: - ASP Isotopes plans to spin out QLE as a separate public company in 2H 2025, enabling focused growth in nuclear fuels while ASP drives innovation in medical and industrial isotopes. The board realignment supports regulatory and capital planning efforts related to the spinoff. 📄 Read the Full Announcement 🔗 https://lnkd.in/eZ7_ZwC5 Nuclear for Climate Semiconductor Nation - Campus Connect Nuclear #RedChip #RedChat #ASPIsotopes #NuclearEnergy #Isotopes #Sustainability #Investing #GreenTech

📢 Win-Light Boosts Stake in ConnectM Technology Solutions (Nasdaq: CNTM), Strengthening Buy-Out Group’s Position Win-Light Global acquired an additional 1.48M shares of ConnectM Technology Solutions, increasing the Buy-Out Group’s total holdings to 24.5% of shares outstanding. 💡 Why This Matters to Investors: - Buyout Proposal Strengthens: The move further supports the Buy-Out Group’s $1.60/share cash offer, implying a ~$62M equity valuation. - Strategic Signal: Increased ownership suggests strong conviction in ConnectM Technology Solutions' energy tech platform. - Board Review Underway: ConnectM's Board, with advisor ThinkEquity LLC, is evaluating the buyout proposal. 📄 https://lnkd.in/eu3_DZA3 Electrification Institute S&P Global Commodity Insights GE Vernova's Electrification businesses #TechStocks #MicroCap #EnergyTech #MergersAndAcquisitions #Investing #BuyoutProposal

🎤 Processa Pharmaceuticals (Nasdaq: PCSA) to Present at World Orphan Drug Congress 2025 Dr. David Young, Founder & President of R&D, will speak on applying FDA’s Project Optimus to rare diseases—showcasing Processa Pharmaceuticals' approach to designing safer, more effective therapies. 💡 Why It Matters • Aligns Processa Pharmaceuticals with FDA-backed innovation • Highlights leadership in rare disease drug design • Reinforces focus on high-value orphan markets 📍Full details: https://lnkd.in/eBhnFxYg Biotechnology Biotechnology News #PCSA #Biotech #RareDiseases #Oncology #FDA #ProjectOptimus #BiotechInvesting

📣 Venu Holding Corporation (NYSE American: VENU) Investor Webinar Set for April 21 Mark your calendars: VENU is hosting an investor webinar on Monday, April 21 at 4:15 PM ET, offering key insights into the company’s strategic growth and upcoming developments. 🎯 Why This Matters to Investors: - Expansion Momentum: VENU recently announced the acquisition of a high-traffic site in Centennial, Colorado—part of its multi-market rollout of upscale indoor music venues featuring Luxe FireSuites and exclusive fractional ownership options. - Innovative Business Model: With hospitality-driven venues like The Hall at Bourbon Brothers and partnerships with major players like AEG Presents and Troy Aikman, VENU is reshaping the premium entertainment landscape. - Growth Markets: Active in Colorado, Georgia, and soon Texas and Oklahoma, VENU is tapping into fast-growing regional economies with strong consumer demand for elevated live entertainment experiences. 🔗 Join the webinar to learn more about VENU's expansion plans and investor-focused strategy: https://lnkd.in/d3RHCFrf VenuesNow Real Estate EIGHT Elite Light Lager #RedChip #RedChat #VENU #LiveEntertainment #RevenueGrowth #Investing #SmallCapStocks #Hospitality

China halts critical rare earth mineral exports as Trump teases new tariffs. Nova Minerals Limited (Nasdaq: NVA) developing a ~9.9M/Oz gold + antimony asset in America's next major critical minerals district. 🖇️ https://lnkd.in/edGv5PXC #NovaMinerals #RedChipClient #RedChat #preciousmetals #antimony #Alaska #goldrush #Gold #MiningStocks

🧠 Nexalin Technology (Nasdaq: NXL) Granted US Patent for Drug-Free Brain Stimulation in Addiction Treatment Nexalin Technology has been granted a U.S. patent for its Deep Intracranial Frequency Stimulation (DIFS™) tech—a non-invasive solution targeting opioid, alcohol, and stimulant use disorders. 💡 Why This Matters for Investors: ✅ Strengthens IP Portfolio: New patent reinforces Nexalin Technology's leadership in neuromodulation for addiction treatment. ✅ High-Impact Market: Substance use disorders affect millions globally—Nexalin's drug-free alternative offers a scalable path to recovery. ✅ Strategic Edge: DIFS™ targets neural circuits tied to cravings, anxiety, and depression—key relapse drivers—positioning Nexalin Technology at the forefront of brain-based therapies. 🔗 https://lnkd.in/ekb249Gc Neuroscience News Neuroscience Biotechnology #Nexalin #RedChip #RedChat #Biotech #MentalHealth #PTSD #FinancialNews #Investing

📢 Connect Biopharma (Nasdaq: CNTB) Hosts Investor Webinar Tomorrow at 4:15 PM ET Connect Biopharma invites investors to its upcoming webinar to discuss corporate strategy and pipeline priorities—including next steps for rademikibart in acute asthma and COPD care. 💡 Why This Matters to Investors: - With FDA alignment now secured, Connect Biopharma is preparing to launch two parallel Phase 2 trials in Q2 2025 targeting a massive unmet need—acute exacerbations of asthma and COPD. This area impacts over 2.3 million patients annually in the U.S. alone and currently has no approved biologics. With promising early efficacy and a clear clinical roadmap, Connect Biopharma is one to watch heading into mid-2025. 🔗 https://lnkd.in/etbYgKku Biotechnology Biotechnology, Biomedicine and Bioengineering #CNTB #Asthma #COPD #Biotech #ClinicalTrials #RespiratoryCare #Investing #finance

💰 Can-Fite (NYSE American: CANF) $685M in Potential Revenue from Global Partnerships Can Fite BioPharma (CANFY) projects up to $685.9M in future revenue from its collaborations for lead drug candidates Piclidenoson and Namodenoson, based on milestones, royalties, and licensing terms. 🌍 7 Partners Across Key Markets 📈 Indications: Psoriasis, Liver & Pancreatic Cancer, MASH 📅 Forecasted launches: 2027–2029 (pending approvals) 🔬 Backed by global licensing, Can-Fite's pipeline of Phase III assets are positioned for significant long-term value. 📄 Full Release: https://lnkd.in/ej_jHYZH Biotechnology Biotech Network #RedChip #RedChat #CANF #Biotech #LicensingDeals #DrugDevelopment #Oncology #MASH #Psoriasis #BiotechInvesting #RevenueGrowth

🚨 Gorilla Technology (Nasdaq: GRRR) Confirms $4.5M+ in Buybacks To-Date as AI Veteran Joins Americas Expansion Gorilla Technology Group has repurchased over $4.5M in stock under its $10M buyback plan—signaling confidence in long-term value. Gorilla also announced further strengthening of its team with appointment of AI leader Satish Venkatesan as Chief Solutions Strategist – Americas. 💡 Why It Matters 🔹 Buybacks reinforce management’s conviction in Gorilla Technology Group's intrinsic value 🔹 Venkatesan brings 30+ years’ experience, incl. $100M+ digital portfolios at Cognizant 🔹 He’ll lead U.S. & LATAM strategy, incl. the Amazon Smart Corridor 📄 Full Release: https://lnkd.in/ejhMHXTk #RedChip #RedChat #SmartGrid #AI #SaaS #SmartWarehousing #Thailand #TechInvesting #Infrastructure